drugset / Trial / NCT06423352
A Study to Evaluate Zilebesiran in Japanese Patients With Mild to Moderate Hypertension
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to evaluate the safety, tolerability, efficacy, pharmacodynamics (PD) and pharmacokinetics (PK) of zilebesiran in Japanese patients with mild to moderate hypertension.
Timeline
- Start
- 2024-06-05
- Primary completion
- 2025-07-17
- Completion
- 2025-07-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Zilebesiran | Unknown | — | Subcutaneous |